Core Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Core Laboratories has a total shareholder equity of $256.4M and total debt of $139.9M, which brings its debt-to-equity ratio to 54.5%. Its total assets and total liabilities are $600.5M and $344.0M respectively. Core Laboratories's EBIT is $56.2M making its interest coverage ratio 4.2. It has cash and short-term investments of $21.5M.
Key information
54.5%
Debt to equity ratio
US$139.87m
Debt
| Interest coverage ratio | 4.2x |
| Cash | US$21.47m |
| Equity | US$256.42m |
| Total liabilities | US$344.05m |
| Total assets | US$600.47m |
Recent financial health updates
Is Core Laboratories (NYSE:CLB) Using Too Much Debt?
Nov 12
We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt
Jul 15Recent updates
Is Core Laboratories (NYSE:CLB) Using Too Much Debt?
Nov 12Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?
Sep 19What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E
Aug 14We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt
Jul 15These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong
Jun 25It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year
May 02Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?
Mar 26Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price
Mar 02Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts
Nov 09Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Sep 08Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up
Aug 16Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors
Jul 05The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence
May 25Financial Position Analysis
Short Term Liabilities: CLB's short term assets ($235.2M) exceed its short term liabilities ($94.9M).
Long Term Liabilities: CLB's short term assets ($235.2M) do not cover its long term liabilities ($249.1M).
Debt to Equity History and Analysis
Debt Level: CLB's net debt to equity ratio (46.2%) is considered high.
Reducing Debt: CLB's debt to equity ratio has reduced from 153.4% to 54.5% over the past 5 years.
Debt Coverage: CLB's debt is well covered by operating cash flow (39.5%).
Interest Coverage: CLB's interest payments on its debt are well covered by EBIT (4.2x coverage).